Research

CurePSP recognizes that the fight against PSP, CBD, and other disorders can now take a new direction, capitalizing on a number of recent discoveries, exciting ongoing work, and new hypotheses. Please watch this video to learn more about PSP and CBD research. At Neuro 2021, Adam Boxer, MD, PhD, discusses how to successfully pave a new road towards PSP therapies.

Paving a New Road to PSP Therapies - Adam Boxer, MD, PhD

Paving a New Road to PSP Therapies - Adam Boxer, MD, PhD

Research Focus

Based on this road map and goals, we composed a document with our research focus for 2022-23. The key areas of interest are:

– autophagy/proteostasis
– cell replacement therapy/regenerative approaches
– diagnostic markers in very early stage disease
– environmental causes and geographical clusters
– epigenetics
– GSK3ß and other kinases/phosphorylases
– inflammation
– Mendelian families
– nucleochromatin
– rehabilitation strategies for motor and nonmotor deficits
– RNA-based neuroprotection
– single cell sequencing
– sleep physiology
– symptomatic drug trials
– synaptic dysfunction/loss
– tau strains

For further information contact Kristophe Diaz, PhD, Executive Director and Chief Science Officer, at diaz@curepsp.org.

Research Grants

New Venture Grants applications deadline is October 14th, 2022.

CurePSP provides “seed funding” to investigators who have innovative ideas that need “proof of concept” in order to qualify for larger funding sources.

CurePSP will fund studies on PSP and CBD with a particular interest in (i) molecular and cellular (pathological) mechanisms that may operate also in related diseases and (ii) translational clinical research involving PSP and CBD patients.

We provide grants to scientists of up to $100,000 for one- or two-year studies. These are carefully evaluated by our distinguished global Scientific Advisory Board (SAB) in collaboration with our Vice President-Scientific Affairs and the Board of Directors Research Committee. Because of that, these studies offer donors the opportunity to name and be involved with hand-selected and intensively administered research that provides the greatest return on investment for the donor dollar.

Please visit our Venture Grants page to learn more about them.

Please visit our currently funded venture grants page to learn more about currently funded research. 

Please visit our completed venture grants to learn more about completed research studies.

CurePSP supports large research projects conducted by leading senior investigators at major institutions. These studies may have a longer time horizon and broader scope than our Venture Grants, and may involve joint funding from other sources. These studies have the potential of making major strides in the quest to find treatment and cure for neurodegeneration and as such provide significant opportunities for donor recognition and involvement.

Please visit our Enterprise Grants page to learn more about this research. 

The CurePSP Urso Student Fellowship supports students conducting summer research projects focused on PSP, CBD, and related diseases. This program is supported by the Paul and Ruth Urso Memorial Research Fund. The goal of this fellowship program is to encourage students at all post-secondary levels to pursue research in this field in the hope of making PSP or CBD a long-term area of research interest. Projects may be in basic, translational, clinical, or epidemiological aspects of PSP and CBD.

Please visit our Student Fellowship page to learn more. 

CurePSP Brain Tissue Donation Program

Brain donations are a precious gift for science, establishing a long-term legacy of scientific progress that otherwise would not be possible. Brain tissue donated through this program is carefully studied by researchers working hard to understand human neurobiology and the causes of neurodegeneration. Brain donations have led, and will lead to breakthroughs in science, the development of treatments and ultimately, cures for PSP, CBD, MSA and related diseases.

PSP Research Roundtable

The PSP Research Roundtable is a pre-competitive collaboration involving patient advocacy organizations, academia, and selected industry leaders. Its mission is to represent the field in addressing bottlenecks and accelerating the development of new treatments for PSP and other primary tauopathies.

Prime of Life Brain Initiative

In 2018, CurePSP announced a landmark partnership with the Rainwater Charitable Foundation. The goal of this partnership is to develop collaborative research efforts to find treatments and cures for neurodegenerative diseases. Importantly, this partnership connects the primary focus of CurePSP, patients and caregivers, with the many breakthroughs and advances enabled by Rainwater Charitable Foundation’s flagship research program, the Tau Consortium. This year, the partnership focuses on the Tau Consortium Stem Cell group and the advances needed to better model neurodegenerative diseases using human-derived systems.

PSP Genetics Consortium

genetics-cons-croppedThe PSP Genetics Consortium is a group of neurologists, geneticists, and other neuroscientists from the United States, United Kingdom, and Germany, studying the underlying genetics of PSP. The goal of this multi-national approach is to search the entire human genome for genes linked to PSP and related disorders. The PSP Genetics Consortium is a collaboration between CurePSP and the Tau Consortium. 

The FTD Disorders Registry

The Registry is an online database to collect information from those affected by all types of prime of life brain diseases, such as PSP, CBD, and related. Persons diagnosed, (current/former) caregivers, family, and friends can join. As a member of the Registry, you can help us advance the science and move faster toward finding treatments and cures. Join the registry here.